Moloney Securities Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-14,750
Closed -$593K 436
2021
Q4
$593K Hold
14,750
0.1% 216
2021
Q3
$600K Sell
14,750
-4,500
-23% -$188K 0.11% 218
2021
Q2
$874K Hold
19,250
0.16% 161
2021
Q1
$803K Hold
19,250
0.16% 154
2020
Q4
$822K Buy
19,250
+4,500
+31% +$162K 0.18% 146
2020
Q3
$388K Buy
+14,750
New +$411K 0.1% 207

Other funds holding HALO

Moloney Securities Asset Management's HALO Position: Q1 2022 in Review

Moloney Securities Asset Management sold out of Halozyme (HALO) in Q1 2022, closing a stake of 14,750 shares — an estimated $593K sold.

Moloney Securities Asset Management first reported a position in HALO in Q3 2020 and held it in 6 quarters. The position peaked at $874K in Q2 2021. 316 funds tracked by Wall St. Rank hold HALO as of Q1 2022.

  • Moloney Securities Asset Management reported no remaining Halozyme position as of Q1 2022 after selling out during the quarter.
  • Moloney Securities Asset Management sold 14,750 Halozyme shares in Q1 2022, an estimated $593K.
  • Moloney Securities Asset Management first reported a position in Halozyme in Q3 2020 and held it in 6 quarters.
  • Moloney Securities Asset Management's Halozyme position peaked at $874K in Q2 2021.
  • 316 funds tracked by Wall St. Rank held Halozyme as of Q1 2022.

Based on Moloney Securities Asset Management's 13F filing for Q1 2022, filed 10 May 2022.